Records 1 - 5
| Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
BMJ open 2019 Aug 9 (8): e027940.
Yang Seungwon, Hwang Se Jung, Park Jung Yun, Chung Eun Kyoung, Lee Jangik
| Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury.
Basic & clinical pharmacology & toxicology 2019 Jun .
Jin Shasha, Li Xuesong, Fan Yujuan, Fan Xiaofang, Dai Yu, Lin Haishu, Cai Weimin, Yang Jialin, Xiang Xiaoqia
| [Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2016 Jul 37 (7): 925-9.
Chen R, Wang J, Tang S W, Lyu X Z, Zhang Y, Wu S S, Xia Y Y, Zhan S
| Association of CYP2C9*2 with bosentan-induced liver injury.
Clinical pharmacology and therapeutics 2013 Dec 94 (6): 678-86.
Markova S M, De Marco T, Bendjilali N, Kobashigawa E A, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie A E, Khojasteh C, McGlothlin D, Wu A H B, Hsueh W-C, Witte J S, Schwartz J B, Kroetz D
| Polymorphisms in drug transporter genes (ABCB1, SLCO1B1 and ABCC2) and hepatitis induced by antituberculosis drugs.
Tuberculosis (Edinburgh, Scotland) 2012 Jan 92 (1): 100-4.
Kim Sang-Hoon, Kim Sang-Heon, Lee Jae-Hyung, Lee Byoung-Hoon, Kim Youn-Seup, Park Jae-Seuk, Jee Young-K